combination chemotherapy Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (1)

Phase 3 (1)
Phase 4 (1)

Interventional (2)

Herui Yao (1)
IRCCS San Raffaele (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadadvanced breast cancer

I am/have/hadchemotherapy regimen

I am/have/hadmetastasis

I am/have/hadcancer chemotherapy

I am/have/hadpancreatic adenocarcinoma

I am/have/hadpdac

I am/have/hadblood test

I am/have/hadmaintenance therapy

I am/have/hadimmunohistochemistry

I am/have/hadneutrophil count

I am/have/hadpancreatic ductal adenocarcinoma

I am/have/hadresectable pancreatic ductal adenocarcinoma

I am/have/hadcancer

I am/have/hadalt/ast

I am/have/hadalopecia

I am/have/hadductal adenocarcinoma

I am/have/hadHER2

I am/have/hadhair thinning

I am/have/hadserum total bilirubin level

I am/have/hadmaintenance treatment

added new label for I am/have/had

more

I am looking for

I am looking forcapecitabine

I am looking forher-2

I am looking forgemcitabine

I am looking forcisplatin

I am looking forfulvestrant

I am looking forpaclitaxel

I am looking forerbb2

I am looking forchromogenic in situ hybridization

I am looking forgrowth factor

I am looking forhuman epidermal growth factor

I am looking forepidermal growth factor

I am looking forcish

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Recruiting

Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Combination Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

This phase III trial aims to compare the progression free survival (PFS) and safety of fulvestrant or capecitabine as maintenance therapy after first-line combined chemotherapy in hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer.

advanced breast cancer

her-2

chemotherapy regimen

metastasis

cancer chemotherapy

0 views
19 Feb, 2024
7 locations

Phase 4
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

PAXG Out in the Country

The objective of this study is to assess the reproducibility of PAXG regimen as first-line/primary chemotherapy in daily clinical practice in Pancreatic Ductal Adenocarcinoma (PDAC) borderline resectable, locally advanced or metastatic patients out of a large volume center.

pancreatic ductal adenocarcinoma

resectable pancreatic ductal adenocarcinoma

metastasis

gemcitabine

serum total bilirubin level

0 views
19 Feb, 2024
30 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.